ingmitai capsule for the treatment of chronic prostatitis
- Conditions
- Chronic Prostatitis
- Registration Number
- ITMCTR2000003084
- Lead Sponsor
- Peking University First Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- Not specified
1. Chronic prostatitis: Chronic and recurrent pelvic discomfort or pain (NIH-CPSI pain score >= 4) lasting more than 3 months;
2. The patients accepted urine routine, EPS routine and prostate color ultrasound examination and were willing to follow-up on time;
3. According to the 2014 edition of the China Society of Urology's guidelines for the diagnosis and treatment of chronic prostatitis, treatment options are determined by doctors The use of proprietary Chinese medicine according to the Chinese Society of Integrated Traditional Chinese and Western medicine andrology 2015 edition of chronic prostatitis integrated traditional Chinese and Western medicine expert consensus using Ningbitai capsules;
4. Volunteer and agree to sign an informed consent.
1. Patients who were involved in other clinical studies;
2. Urine routine or color doppler ultrasound examination of the prostate suggested other organic diseases of the Urinary System;
3. Patients with serious cardiovascular, cerebrovascular, liver, Kidney, hematopoiesis and psychosis;
4. People who are known to be allergic to Ningmitai capsules or some of their ingredients.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The NIH - CPSI score;
- Secondary Outcome Measures
Name Time Method